Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,006 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Holz FG, Dugel PU, Weissgerber G, Hamilton R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A, Schmidt A, Escher D, Sararols L, Souied E. Holz FG, et al. Among authors: hamilton r. Ophthalmology. 2016 May;123(5):1080-9. doi: 10.1016/j.ophtha.2015.12.030. Epub 2016 Feb 20. Ophthalmology. 2016. PMID: 26906165 Free article. Clinical Trial.
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG. Michaelides M, et al. Among authors: hamilton rd. Ophthalmology. 2010 Jun;117(6):1078-1086.e2. doi: 10.1016/j.ophtha.2010.03.045. Epub 2010 Apr 22. Ophthalmology. 2010. PMID: 20416952 Clinical Trial.
Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1.
Michaelides M, Fraser-Bell S, Hamilton R, Kaines A, Egan C, Bunce C, Peto T, Hykin P. Michaelides M, et al. Among authors: hamilton r. Retina. 2010 May;30(5):781-6. doi: 10.1097/iae.0b013e3181d2f145. Retina. 2010. PMID: 20464787 Clinical Trial.
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG. Rajendram R, et al. Among authors: hamilton rd. Arch Ophthalmol. 2012 Aug;130(8):972-9. doi: 10.1001/archophthalmol.2012.393. Arch Ophthalmol. 2012. PMID: 22491395 Clinical Trial.
Valacyclovir in the treatment of acute retinal necrosis.
Taylor SR, Hamilton R, Hooper CY, Joshi L, Morarji J, Gupta N, Lightman SL. Taylor SR, et al. Among authors: hamilton r. BMC Ophthalmol. 2012 Sep 5;12:48. doi: 10.1186/1471-2415-12-48. BMC Ophthalmol. 2012. PMID: 22947428 Free PMC article.
Implementation of a nurse-delivered intravitreal injection service.
DaCosta J, Hamilton R, Nago J, Mapani A, Kennedy E, Luckett T, Pavesio C, Flanagan D. DaCosta J, et al. Among authors: hamilton r. Eye (Lond). 2014 Jun;28(6):734-40. doi: 10.1038/eye.2014.69. Epub 2014 Apr 4. Eye (Lond). 2014. PMID: 24699166 Free PMC article.
3,006 results